NanoLogix Announces European Clinical Trial of Its Rapid Detection Kits
June 7, 2011
HUBBARD, OH - NanoLogix (OTC MARKETS: NNLX), a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today its BioNanoFilter (BNF) technology will undergo a clinical trial, led by Dr. Gian Carlo Di Renzo of the University of Perugia in Italy. The 300 patient trial will study the speed and [...]
Corning Adds New Ceramic Reactor to its Advanced-Flow™ Reactor Product Line
June 7, 2011
AVON, France - Corning SAS, a subsidiary of Corning Incorporated (NYSE: GLW) of Corning, N.Y., announced today that it will feature the Corning® Advanced-Flow™ G4 Ceramic Reactor at Chemspec Europe in Geneva, Switzerland, June 15-16, 2011. The Advanced-Flow G4 Ceramic Reactor is the company’s newest reactor product and the first to use ceramic-based technology. Corning’s [...]
hte Helps BP Accelerate Commercialisation of Fischer-Tropsch Process
June 7, 2011
HEIDELBERG - hte –the high throughput experimentation company extends its collaboration with BP International Ltd. in the field of Fischer-Tropsch synthesis. The BP Conversion Technology Centre is continuing to work with hte in the field of Fischer-Tropsch catalysis and process. The Fischer-Tropsch process is used to convert syngas into synthetic fuels and lubricants, and due [...]
Stratos Genomics Announces Financing for Validation of SBXTM Genome Sequencing Technology
June 7, 2011
SEATTLE, WA - Stratos Genomics Inc. today announced $2.1 million of funding to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The funds are provided by existing shareholders as an "up round" to August 2010's $4 million financing and under the same Series-A terms. "We are fortunate [...]
Expression Analysis Launches PacBio RS Sequencing Services
June 7, 2011
DURHAM, N.C. - EA, long known as an industry leader in adopting new genomic technologies announced today that is has begun offering sequencing services on Pacific Biosciences’ PacBio RS system. EA is the first US commercial service provider to offer sequencing on this platform and PacBio selected EA to be their recommended North American commercial [...]
ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
June 7, 2011
San Antonio Tx - ImaginAb, Inc. is pleased to announce the availability of custom radiolabeling services for proteins, peptides and other macromolecules as of the 1st of July 2011. This is part of the company’s ongoing initiative to broaden the range of product and service offerings to the biopharma and research community and is synergistic [...]
June 7, 2011
DENVER - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity. The Thermo Scientific TSQ Quantum XLS Ultra delivers the increased matrix selectivity needed for challenging applications that require lower levels [...]
June 7, 2011
SAN DIEGO - Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the acceptance for publication of the manuscript titled, "Fetal RHD Genotype Detection from Circulating Cell-Free Fetal DNA in Maternal Plasma in Non-Sensitized RhD Negative Women." The article is currently available online and will appear in the next [...]
June 7, 2011
BETHESDA, Md. - Media Cybernetics announces the release of Gel-Pro Analyzer Version 6.3 image analysis software. Designed for molecular biologists, this software extracts valuable qualitative and quantitative information from electrophoretic gels, blots and colonies. This latest version of Gel-Pro Analyzer includes support for 32- and 64-bit Windows Vista and Windows 7 operating systems. Gel-Pro Analyzer [...]
June 7, 2011
TORONTO - SQI Diagnostics Inc. (the "Company", "SQI Diagnostics" or "SQI") (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has received notice that the United States Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) diagnostics platform and its [...]

